Skip to content

Public FDA record

Z-0770-04: Giardia/ Cryptosporidium Rapid In-vitro diagnostic Test kits. These are sold under two names as follows:

Recall record Z-0770-04 for Genzyme Diagnostics. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0770-04
Company in FDA record
Genzyme Diagnostics
FDA classification date
Jul 20, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

False Positive results.

Source facts

Action
Recall was by letters sent in March 2004 requesting distributors subrecall to customers and have them discard/destroy the lots in question.
Initiated
2004-02-23
Root cause
Other
Terminated
2004-09-15
Distribution
Product was manufactured for two firms who subdistributed it, Meridian Bioscience of Cincinnati OH and Becton Dickenson, Sparks MD.
Recall number
Z-0770-04
Recall status
Terminated
CDRH record ID
31968
FDA classified
2004-07-20
Recall event number
28473

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗